{"brief_title": "Treatment of Advanced AIDS Patients With Dextrin Sulfate", "brief_summary": "The purpose of this study is to look at the safety and effectiveness of dextrin sulfate in AIDS patients who have failed conventional anti-HIV treatment.", "detailed_description": "Patients have intraperitoneal (IP) catheter placement done at study entry. Infusion with the carrier vehicle (icodextrin 4%) begins 2 weeks later, and 2 days after that, treatment with dextrin sulphate (DS) commences. DS is given three times per week. A nurse delivers initial treatments and the patient and caregiver will be trained to give subsequent treatments until DS has been given a total of 8 weeks. Patient evaluations are done regularly during treatment and observation continues for 24 weeks.", "condition": "HIV Infections", "intervention_type": "Drug", "intervention_name": "Dextrin 2-sulfate", "criteria": "Inclusion Criteria Patients may be eligible for this trial if they: - Are HIV-positive. - Have been diagnosed with AIDS and are under treatment to prevent opportunistic (AIDS-related) infection. - Have had a CD4 cell count greater than 50 microL for at least the past 3 months. - Have had a viral load of at least 50,000 copies/ml for at least the past 3 months. - Have used up all other treatment options. - Are able to understand and give written consent. Exclusion Criteria Patients may not be eligible for this trial if they: - Have been in any other study in the 6 weeks before beginning this study. - Have an active, opportunistic infection or other infection. - Have any other long-term medical condition or nervous disorder that might make it difficult for them to finish the study.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00004987.xml"}